院内转运中自适应分钟通气量的随机对照试验研究方案
本研究为单中心、开放标签、随机对照非劣效性试验,计划纳入50例需转运的成人有创机械通气患者,1:1随机分为自适应分钟通气量(AMV)组或转运前通气模式组,主要终点为转运前30分钟至转运后10分钟动脉血二氧化碳分压(PaCO₂)的变化,旨在评估AMV在院内转运中的安全性和有效性。
要点
- AMV组与常规通气组比较转运前后PaCO₂变化,非劣效性设计。
- 次要终点包括氧合指数、气道峰压、动态顺应性和快速浅呼吸指数变化。
- 采用意向性治疗和符合方案分析,缺失数据用多重插补处理。
核心结论
- 本试验将首次随机评估AMV在危重患者院内转运中的表现,可能为转运通气策略提供安全有效的替代方案。
研究设计与样本
- 单中心、开放标签、随机对照非劣效性试验,在北京协和医院开展,计划纳入50例成人有创机械通气需转运患者,1:1随机分组。
关键数值与推荐
- 主要终点为转运前30分钟至转运后10分钟PaCO₂的变化。
- 次要终点包括氧合指数(PaO₂/FiO₂)、气道峰压、动态顺应性和快速浅呼吸指数的变化。
- 随机化采用置换区组随机化,进行意向性治疗和符合方案分析,缺失数据用多重插补处理。
临床怎么用
- 若AMV非劣效于常规通气模式,可为危重患者院内转运提供一种自动维持目标分钟通气量的通气策略。
局限性
- 单中心设计且样本量相对较小。
- 试验为开放标签,未设盲。
- 注册为回顾性注册(2025年9月23日)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intra-hospital transport of critically ill, mechanically ventilated patients is associated with significant physiological risks. Adaptive Minute Ventilation (AMV) is a closed-loop ventilation mode that automatically maintains target minute ventilation. While AMV has shown promise in intensive care unit settings, its performance during intrahospital transport has not yet been evaluated. This trial aims to assess the safety and efficacy of AMV compared with conventional ventilation strategies during patient transport. METHODS: This is a single-centre, open-label, randomized controlled non-inferiority trial conducted at Peking Union Medical College Hospital. Fifty adult patients receiving invasive mechanical ventilation and requiring transport will be randomly assigned (1:1) to either AMV or their pre-transport ventilation mode. The primary endpoint is the change in arterial carbon dioxide pressure (PaCO₂) from 30 min before to 10 min after transport. Secondary outcomes include changes in oxygenation index (PaO₂/FiO₂), peak airway pressure, dynamic compliance, and rapid shallow breathing index. Randomization will be performed using permuted block randomization. Both intention-to-treat and per-protocol analyses will be conducted. Missing data will be handled using multiple imputation. The study protocol has been reviewed and approved by the Ethics Committee of Peking Union Medical College Hospital (Approval No. I-25PJ0781). It was registered in the Chinese Clinical Trial Registry (ChiCTR2500109659) on 23 September 2025 as a retrospective registration. DISCUSSION: This trial will be the first randomized study to evaluate AMV during intrahospital transport of critically ill patients. The findings will address an important evidence gap in transport ventilation strategies, potentially informing clinical practice on whether AMV provides a safe and effective alternative to conventional modes. By employing a non-inferiority design and standardized transport protocols, the study seeks to generate robust and clinically relevant evidence despite its single-centre setting and relatively small sample size. TRIAL REGISTRATION: Approved by the Ethics Committee of Peking Union Medical College Hospital (Approval No. I-25PJ0781). TRIAL REGISTRATION: ChiCTR, ChiCTR2500109659. Registered 23 September 2025, https://www.chictr.org.cn/hvshowproject.html?id=284847 .
引用
- Zhu P, Wang J, Gui Y, et al. Adaptive minute ventilation during intrahospital transport: study protocol for a randomized controlled trial. Trials. 2026. PMID: 41826997. doi:10.1186/s13063-026-09575-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。